These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38995261)

  • 1.
    Thomas KA; Struble CA; Stenersen MR; Moore K
    J Law Med Ethics; 2024; 52(S1):75-80. PubMed ID: 38995261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of State Child Abuse Policies and Mandated Reporting Policies With Prenatal and Postpartum Care Among Women Who Engaged in Substance Use During Pregnancy.
    Austin AE; Naumann RB; Simmons E
    JAMA Pediatr; 2022 Nov; 176(11):1123-1130. PubMed ID: 36121649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnant Women with Substance Use Disorders - The Harm Associated with Punitive Approaches.
    Haffajee RL; Faherty LJ; Zivin K
    N Engl J Med; 2021 Jun; 384(25):2364-2367. PubMed ID: 34161722
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.
    Faherty LJ; Kranz AM; Russell-Fritch J; Patrick SW; Cantor J; Stein BD
    JAMA Netw Open; 2019 Nov; 2(11):e1914078. PubMed ID: 31722022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternity Care in Crisis.
    Johnson T
    State Legis; 2019; 45(1):16-9. PubMed ID: 30676709
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal mortality and morbidity in the United States: where are we now?
    Creanga AA; Berg CJ; Ko JY; Farr SL; Tong VT; Bruce FC; Callaghan WM
    J Womens Health (Larchmt); 2014 Jan; 23(1):3-9. PubMed ID: 24383493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Punitive policies: constitutional hazards of non-consensual testing of women for prenatal drug use.
    VanRaalte DB
    Health Matrix Clevel; 1995; 5(2):443-82. PubMed ID: 10152586
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of U.S. State Laws Requiring Health Care Provider Reporting of Perinatal Substance Use.
    Jarlenski M; Hogan C; Bogen DL; Chang JC; Bodnar LM; Van Nostrand E
    Womens Health Issues; 2017; 27(3):264-270. PubMed ID: 28129942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use disorder treatment admissions and state-level prenatal substance use policies: Evidence from a national treatment database.
    Kozhimannil KB; Dowd WN; Ali MM; Novak P; Chen J
    Addict Behav; 2019 Mar; 90():272-277. PubMed ID: 30472535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance Use-Associated Infant Maltreatment Report Rates in the Context of Complex Prenatal Substance Use Policy Environments.
    Stritzel H
    Child Maltreat; 2024 Nov; 29(4):574-586. PubMed ID: 37955183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Implementation of State and Federal Child Welfare Laws Related to Drug Use in Pregnancy.
    McCOURT AD; White SA; Bandara S; Schall T; Goodman DJ; Patel E; McGINTY EE
    Milbank Q; 2022 Dec; 100(4):1076-1120. PubMed ID: 36510665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2021 Reauthorization of CAPTA - Letting Public Health Lead.
    Lloyd Sieger MH; Rebbe R; Patrick SW
    N Engl J Med; 2021 Oct; 385(18):1636-1639. PubMed ID: 34677917
    [No Abstract]   [Full Text] [Related]  

  • 13. State Policymaking and Stated Reasons: Prenatal Care for Undocumented Immigrants in an Era of Abortion Restriction.
    Fabi RE; Saloner B; Taylor H
    Milbank Q; 2021 Sep; 99(3):693-720. PubMed ID: 34166528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in prenatal substance use screening despite universal screening recommendations: findings from the Pregnancy Risk Assessment Monitoring System, 2016-2018.
    Patel E; Bandara S; Saloner B; Stuart EA; Goodman D; Terplan M; McCourt A; White S; McGinty EE
    Am J Obstet Gynecol MFM; 2021 Sep; 3(5):100419. PubMed ID: 34116233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ohio's Bill 167 fails to increase prenatal referrals for substance abuse.
    Horrigan TJ; Katz L
    J Subst Abuse Treat; 2000 Apr; 18(3):283-6. PubMed ID: 10742643
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal substance abuse and infant health: policy options across the life course.
    Frohna JG; Lantz PM; Pollack H
    Milbank Q; 1999; 77(4):531-70, iii. PubMed ID: 10656032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State-level health policy to improve birth outcomes and reduce infant mortality.
    O'Connor J; Nolan K; O'Neill C
    Health Promot Pract; 2005 Jan; 6(1):12-22. PubMed ID: 15574522
    [No Abstract]   [Full Text] [Related]  

  • 18. Women's opinions of legal requirements for drug testing in prenatal care.
    Tucker Edmonds B; Mckenzie F; Austgen MB; Carroll AE; Meslin EM
    J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1693-1698. PubMed ID: 27609460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations by Education Status in Relationships Between Alcohol/Pregnancy Policies and Birth Outcomes and Prenatal Care Utilization: A Legal Epidemiology Study.
    Roberts SCM; Mericle AA; Subbaraman MS; Thomas S; Kerr W; Berglas NF
    J Public Health Manag Pract; 2020; 26 Suppl 2, Advancing Legal Epidemiology(Suppl 2 ADVANCING LEGAL EPIDEMIOLOGY):S71-S83. PubMed ID: 32004225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between State-Level Criminal Justice-Focused Prenatal Substance Use Policies in the US and Substance Use-Related Foster Care Admissions and Family Reunification.
    Sanmartin MX; Ali MM; Lynch S; Aktas A
    JAMA Pediatr; 2020 Aug; 174(8):782-788. PubMed ID: 32421179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.